RAB7A and melanoma: We have shown here that knockout of either Rab7a or TPC2 in melanoma lines, in particular those that express high levels of MITF result in similar phenotypes i.e., reduction of proliferation, migration, invasion, and tumor growth in vitro and in vivo.